HMG-CoA Reductase Inhibitor [EPC]

373656 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN ROSUVASTATIN ATORVASTATIN CALCIUM EZETIMIBE AND SIMVASTATIN PITAVASTATIN MAGNESIUM

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 26565
1 NAUSEA 23887
2 DYSPNOEA 23021
3 DRUG INEFFECTIVE 22726
4 DIARRHOEA 22639
5 DIZZINESS 19465
6 PAIN 17444
7 HEADACHE 17400
8 ASTHENIA 16492
9 OFF LABEL USE 16038
See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RHABDOMYOLYSIS 8963 0.2147
1 BLOOD CREATINE PHOSPHOKINASE INCREASED 3690 0.1280
2 CORONARY ARTERY DISEASE 3180 0.1049
3 RENAL FAILURE ACUTE 4154 0.0978
4 CHRONIC KIDNEY DISEASE 7015 0.0922
5 TYPE 2 DIABETES MELLITUS 2973 0.0882
6 MYALGIA 14533 0.0854
7 ANGINA PECTORIS 2315 0.0807
8 ACUTE MYOCARDIAL INFARCTION 2377 0.0805
9 TRANSIENT ISCHAEMIC ATTACK 2535 0.0751
See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]